Leteneux C - Search Results

1

Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study.

Moro-Sibilot D, Vergnenegre A, Smit EF, Toy E, Parente B, Schmitz S, Kraaij K, Visseren-Grul C, Soldatenkova V, Arellano J, Leteneux C. Moro-Sibilot D, et al. Among authors: leteneux c. Curr Med Res Opin. 2010 Nov;26(11):2661-72. doi: 10.1185/03007995.2010.525489. Epub 2010 Oct 14. Curr Med Res Opin. 2010. PMID: 20942749

2

Comment and reply on: A comparison of the estimated costs of erlotinib, docetaxel and pemetrexed for the second-line treatment of non-small cell lung cancer from the German healthcare perspective.

Arellano J, Leteneux C. Arellano J, et al. Among authors: leteneux c. J Med Econ. 2008;11(2):363-66; author reply 366-70. doi: 10.3111/13696990802113147. J Med Econ. 2008. PMID: 19450092 Free article. No abstract available.

3

Epidemiology, treatment pattern and health care utilization of myopic choroidal neovascularization: a population based study.

Yang MC, Chen YP, Tan EC, Leteneux C, Chang E, Chu CH, Lai CC. Yang MC, et al. Among authors: leteneux c. Jpn J Ophthalmol. 2017 Mar;61(2):159-168. doi: 10.1007/s10384-016-0496-3. Epub 2017 Jan 6. Jpn J Ophthalmol. 2017. PMID: 28062929

4

Ranibizumab prefilled syringes: benefits of reduced syringe preparation times and less complex preparation procedures.

Souied E, Nghiem-Buffet S, Leteneux C, Bayer S, Derveloy A, Sagkriotis A, Becker G, Cohen SY. Souied E, et al. Among authors: leteneux c. Eur J Ophthalmol. 2015 Nov-Dec;25(6):529-34. doi: 10.5301/ejo.5000629. Epub 2015 May 18. Eur J Ophthalmol. 2015. PMID: 26044375

5

Ranibizumab for the Treatment of Visual Impairment Due to Myopic Choroidal Neovascularization: Cost-Effectiveness Versus Aflibercept.

Leteneux C, Haig J, Xue W, Bhattacharyya S. Leteneux C, et al. Value Health. 2014 Nov;17(7):A608. doi: 10.1016/j.jval.2014.08.2123. Epub 2014 Oct 26. Value Health. 2014. PMID: 27202113 Free article. No abstract available.

6

Transition Probability Estimation Using Repeated Sampling from a Fitted Mixed Model.

Gupta S, Bhattacharyya S, Sonathi V, Bakuli A, Mathur AK, Leteneux C. Gupta S, et al. Among authors: leteneux c. Value Health. 2014 Nov;17(7):A326. doi: 10.1016/j.jval.2014.08.586. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200545 Free article. No abstract available.

7

Ranibizumab, verteporfin photodynamic therapy or observation for the treatment of myopic choroidal neovascularization: cost effectiveness in the UK.

Claxton L, Malcolm B, Taylor M, Haig J, Leteneux C. Claxton L, et al. Among authors: leteneux c. Drugs Aging. 2014 Nov;31(11):837-48. doi: 10.1007/s40266-014-0216-y. Drugs Aging. 2014. PMID: 25300507 Free PMC article. Clinical Trial.

8

Hepatitis C virus in Asia: utility values based on the Short Form-36 questionnaire.

Crawford B, Yeung CK, Tanaka E, Kraemer M, Leteneux C. Crawford B, et al. Among authors: leteneux c. Expert Rev Pharmacoecon Outcomes Res. 2012 Dec;12(6):765-73. doi: 10.1586/erp.12.61. Expert Rev Pharmacoecon Outcomes Res. 2012. PMID: 23252358 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters